Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Towa Pharmaceutical Co ( (JP:4553) ) has shared an update.
Towa Pharmaceutical Co., Ltd. has revised its financial forecasts for the fiscal year ending March 31, 2025, reflecting a slight decrease in net sales and operating profit but a significant increase in ordinary profit and profit attributable to owners of the parent. The adjustments are attributed to foreign exchange gains, valuation of derivatives, and effective tax incentives, which have positively impacted the company’s financial outlook.
More about Towa Pharmaceutical Co
Towa Pharmaceutical Co., Ltd., headquartered in Kadoma, Osaka, is a company engaged in the pharmaceutical industry. It focuses on the development, production, and marketing of generic drugs, catering to a wide market that demands affordable medication options.
Average Trading Volume: 126,107
Technical Sentiment Signal: Hold
Current Market Cap: Yen129.8B
See more insights into 4553 stock on TipRanks’ Stock Analysis page.